[
    [
        {
            "time": "",
            "original_text": "牛市初期医药股或持续发烧，疫苗短期有市梦率风险，但更多优质股3-5年成长逻辑未变",
            "features": {
                "keywords": [
                    "牛市",
                    "医药股",
                    "疫苗",
                    "市梦率",
                    "优质股",
                    "成长逻辑"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "牛市初期医药股或持续发烧，疫苗短期有市梦率风险，但更多优质股3-5年成长逻辑未变",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "六张深度数据图，透视今年涨幅超60%的医药板块",
            "features": {
                "keywords": [
                    "数据图",
                    "医药板块",
                    "涨幅"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "六张深度数据图，透视今年涨幅超60%的医药板块",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药行业重点事项点评：第三批带量采购规则变化较少 市场预期逐步稳定",
            "features": {
                "keywords": [
                    "医药行业",
                    "带量采购",
                    "规则变化",
                    "市场预期"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业重点事项点评：第三批带量采购规则变化较少 市场预期逐步稳定",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]